Charles Schwab
CORZ

Charles Schwab’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Charles Schwab’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,978,568
Closed -$2.57M – 3584
2022
Q3 		$2.57M Buy
1,978,568
+356,738
+22% +$759K ﹤0.01% 2513
2022
Q2 		$2.42M Buy
1,621,830
+472,954
+41% +$2.17M ﹤0.01% 2505
2022
Q1 		$9.46M Buy
+1,148,876
New +$10.1M ﹤0.01% 1991

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Charles Schwab's CORZ Position: Q4 2022 in Review

Charles Schwab sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 1,978,568 shares — an estimated $2.57M sold.

Charles Schwab first reported a position in CORZ in Q1 2022 and held it in 3 quarters. The position peaked at $9.46M in Q1 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • Charles Schwab reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Charles Schwab sold 1,978,568 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $2.57M.
  • Charles Schwab first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Charles Schwab's Core Scientific, Inc. Common Stock position peaked at $9.46M in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.